Research Topics
| S KaatzSummaryAffiliation: Henry Ford Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Update in bridging anticoagulationScott Kaatz
Clinical Associate Professor of Medicine, Associate Residency Program Director, Department of Medicine, Director Anticoagulation Clinics, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA
J Thromb Thrombolysis 31:259-64. 2011....
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapyAjay Srivastava
Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA
Thromb J 6:6. 2008..We assessed the inappropriate underutilization of warfarin in atrial fibrillation patients at our hospital by abstracting individual patient charts...- Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, Michigan 48202, USA
Am J Hematol 87:S141-5. 2012..Also, the pros and cons of the possible use of four factor prothrombin complex concentrate are discussed... 
Determinants and measures of quality in oral anticoagulation therapyScott Kaatz
Henry Ford Hospital, Detroit, MI 48202, USA
J Thromb Thrombolysis 25:61-6. 2008..These issues need to be taken into account when setting quality standards for anticoagulation clinics...- Impact on patient care: patient case through the continuum of careScott Kaatz
Henry Ford Hospital, General Internal Medicine, 2799 W Grand Blvd, Detroit, MI 48202, USA
J Thromb Thrombolysis 29:167-70. 2010..This narrative review uses a case-based approach that brings up practical clinical questions regarding these measures, goals and guidelines as they apply to a patient going through the continuum of care from the hospital to their home... - What you should know about the 2008 American College of Chest Physicians evidence-based clinical practice guidelines (8th) on antithrombotic and thrombolytic therapyScott Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA
J Thromb Thrombolysis 29:219-26. 2010..The objective of this article is to help answer ten common clinical questions frequently faced by anticoagulation management services... - Risk of stroke after surgery in patients with and without chronic atrial fibrillationS Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA
J Thromb Haemost 8:884-90. 2010..The extent to which chronic atrial fibrillation affects the risk of postoperative stroke is largely unknown... - Duration of anticoagulation treatment in patients with venous thromboembolismScott Kaatz
Henry Ford Hospital K 15, 2799 W Grand Blvd, Detroit, MI 48202 2608, USA
J Am Osteopath Assoc 110:638-44. 2010..Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care... - Venous thromboembolism prophylaxis after hospital discharge: transition to preventive careScott Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, MI, USA
Hosp Pract (1995) 39:7-15. 2011..In this article, we review the evidence for both standard- and extended-duration VTE prophylaxis and discuss the difficulties in effectively maintaining VTE prophylaxis during the transition from inpatient to outpatient care... - Venous thromboembolism: what to do after anticoagulation is startedScott Kaatz
Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA
Cleve Clin J Med 78:609-18. 2011.... - The venous side: current directions in anticoagulant therapyS Kaatz
Anticoagulation Clinics, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA
J Am Osteopath Assoc 100:S17-21. 2000..A case scenario (in italics) is integrated into this review to illustrate the cost-effective application of an evidence-based approach... - Academic detailing to improve laboratory testing among outpatient medication usersJennifer Elston Lafata
Department of Internal Medicine, Center for Health Services Research, Henry Ford Health System, Detroit, Michigan, USA
Med Care 45:966-72. 2007..To determine whether group academic detailing with performance feedback increases recommended laboratory monitoring among outpatients dispensed medications... - What do medical records tell us about potentially harmful co-prescribing?Jennifer Elston Lafata
Center for Health Services Research, Henrry Ford Health System, Detroit, USA
Jt Comm J Qual Patient Saf 33:395-400. 2007..Previous efforts document drug-drug interactions in ambulatory care. Yet little is known about medical record documentation or clinical management when interacting medications are received... - Potential drug-drug interactions in the outpatient settingJennifer Elston Lafata
Henry Ford Health System, Detroit, Michigan 48202, Channing Laboratory, Brigham and Women s Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Med Care 44:534-41. 2006..Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern... - The cost-effectiveness of different management strategies for patients on chronic warfarin therapyJ E Lafata
Henry Ford Health System, Detroit, MI 48202, USA
J Gen Intern Med 15:31-7. 2000..To examine the cost-effectiveness of moving from usual care to more organized management strategies for patients on chronic warfarin therapy... - Instruments for evaluating education in evidence-based practice: a systematic reviewTerrence Shaneyfelt
Department of Medicine, University of Alabama School of Medicine, and Department of Veterans Affairs Medical Center, Birmingham, AL 35233, USA
JAMA 296:1116-27. 2006..Teaching of EBP should be evaluated and guided by evidence of its own effectiveness... - Ulnar deep venous thrombosis in a professional baseball pitcher: a case reportJason G Hurbanek
Henry Ford Hospital, Detroit, Michigan, USA
Am J Sports Med 35:2131-4. 2007 - Anticoagulation of pregnant women with mechanical heart valvesJeffrey S Ginsberg
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Arch Intern Med 163:694-8. 2003..We believe a consensus conference among experts in the field to identify key unresolved issues and a commitment by the FDA and industry to perform appropriate studies are now critical... - Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care studyJoseph Menzin
Boston Health Economics, 20 Fox Road, Waltham, MA 02451 1007, USA
Ann Pharmacother 39:446-51. 2005..Anticoagulation clinics are often used to administer warfarin therapy more effectively... - Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and VHarvey D White
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand
Arch Intern Med 167:239-45. 2007..Target INRs are frequently not achieved, and the risk of death, bleeding, myocardial infarction (MI), and stroke or systemic embolism event (SEE) may be related to INR control... - Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocolRafael Perera
Department of Primary Health Care, University of Oxford, UK
J Heart Valve Dis 17:233-8. 2008..In order to overcome these limitations and allow further investigation of the data, the study aim is to undertake an Individual Patient Data (IPD) meta-analysis... - Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)Alex C Spyropoulos
Lovelace Medical Center, Albuquerque, New Mexico, USA
Am J Cardiol 102:883-9. 2008.... - Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?Daniel J Brotman
Department of General Internal Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, E13, Cleveland, OH 44195, USA
Med Clin North Am 87:1205-14. 2003..Immediate repeat colonoscopy with polypectomy is recommended. The clinician is asked to provide periprocedural anticoagulation recommendations... - Angiotensin converting enzyme inhibitors and beta-blockers in African Americans with heart failurePeter A McCullough
Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Beaumont Health Center, Royal Oak, MI 48073, USA
Ethn Dis 13:331-6. 2003..Future, similar analyses other databases should control for the duration of illness to avoid lead-time bias in AA with CHF... - Opportunities for improvement in the diagnosis and treatment of heart failurePeter A McCullough
Department of Basic Science, Cardiology Section, University of Missouri Kansas City School of Medicine, Truman Medical Center, Kansas City, Missouri, USA
Clin Cardiol 26:231-7. 2003..Improved treatment of congestive heart failure (CHF) can slow disease progression, promote clinical stability, and prolong survival...